Verve Therapeutics is Drug Discovery in United States that focus on Verve Therapeutics Inc business. Founded in 2018. They cover business area such as Verve Therapeutics Inc, cardiovascular disease, treatment, chronic management, single-course gene editing medicine, its initial program, two gene, level, blood lipid, patient, familial hypercholesterolemia, life-long severely elevated blood cholesterol.
2018
( 6 years old in 2024 )
Verve Therapeutics Inc
-
500 Technology Square
Suite 901
Cambridge, MA 02139
United States
Private
Verve Therapeutics Inccardiovascular diseasetreatmentchronic managementsingle-course gene editing medicineits initial programtwo genelevelblood lipidpatientfamilial hypercholesterolemialife-long severely elevated blood cholesterol
* We use standard office opening hours in near Verve Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Verve Therapeutics is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Verve Therapeutics business is focusing on Verve Therapeutics Inc.
Verve Therapeutics headquarter office and corporate office address is located in 500 Technology Square Suite 901 Cambridge, MA 02139 United States.
Verve Therapeutics was founded in United States.
In 2024, Verve Therapeutics is currently focus on Verve Therapeutics Inc sector.
Above is snippet of Google Trends for "Verve Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Verve Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
